COMPANY PROFILE

Company Profile

  • Company Name
    aiwell Inc.
  • Establishment
    January 23, 2018
  • Representative
    HIROYUKI MABUCHI
  • Location
    • Head Office
      • 〒102-0084
      9-3 Nibancho, Chiyoda-ku, Tokyo
    • Campus Innovation Center Tamachi
      • 〒108-0023
      Institute of Science Tokyo Campus
      Innovation Center INDEST #302-1

    • Branch Office

      • Sapporo
      〒060-0908
      4-1-20 Kitahachijo Higashi, Higashi-ku, Sapporo-shi, Hokkaido
      2nd Floor, Satudora Holdings
      EZOHUB SAPPORO
    • Proteomics Innovation Center（PIC）

      • PIC Kobe
      〒650-0047

      6-3-7 Minatojima Minamimachi, Chuo-ku, Kobe
      Creative Lab Kobe

      PIC Shin Kawasaki
      〒212-0032
      Room 221, KBIC Main Building, 7-7 Shin-Kawasaki, Saiwai-ku, Kawasaki City, Kanagawa
  • Capital
    630,870,600 yen (including 105,228,900 yen as capital reserve)
    As of May 31, 2024
  • Main Shareholder
    Representative, Yokogawa Electric Corporation, Burroughs Inc, DIGIMERCE Inc, Taisho Pharmaceutical Co., Ltd., Future Food Fund Inc.,North Pacific Bank, Ltd., Contrail LLC, and individual investors
  • Business description
    • Realization of mass image data intercomparison by digital imaging and analysis of proteins from human, animals and other living organisms from trace amounts of samples in collaboration with Institute of Science Tokyo.
    • Providing services to support drug discovery, diagnosis and remote medical care using AI before worsening of symptoms or onset of subjective symptoms under the mission 「Eliminating illnesses from the world and keep people healthy」
  • Suppliers
    Institute of Science Tokyo, Sapporo Medical University, Consadole Co., Ltd., R-body project, Kirin Holdings Co., Ltd., Yokogawa Electric Corporation. Sumitomo Dainippon Pharma Co., Ltd. Taisho Pharmaceutical Co., Ltd.
View in Google Maps